Levelle Nutrition has introduced a groundbreaking product, the Cycle Syncing Protein, tailored specifically to meet the unique nutritional needs of menstruating women throughout their menstrual cycle. This innovative protein powder is formulated with effera™, a precision-fermented lactoferrin developed by Helaina, a biotech company. Unlike traditional bovine-derived lactoferrin, effera™ closely mimics the lactoferrin found in human milk, providing a more bioavailable and effective source of this essential nutrient. Helaina secured $45 million in funding last year to further develop and commercialize effera™, underscoring the growing interest in precision fermentation technologies in the biotech industry.
Historically, protein supplements have primarily been designed based on male physiology, overlooking the specific nutritional requirements of women. The Cycle Syncing Protein from Levelle Nutrition fills this gap by offering a product that is informed by clinical research and formulated by a physician-turned-nutritionist. The protein powder is structured into two distinct phases to align with the different stages of the menstrual cycle. Phase 1, recommended for days 1–14, focuses on supporting recovery and ovulation with a nutrient profile containing protein, complex carbohydrates, and essential micronutrients such as fiber, iron, potassium, magnesium, and zinc. Phase 2, tailored for days 15–28, provides a different nutrient balance to support energy levels, muscle tone, and inflammation resolution, including calcium, phosphorus, potassium, and zinc.
An impressive seven out of ten pre-sale customers have opted for both Phase 1 and Phase 2 of the Cycle Syncing Protein, indicating a strong demand for personalized nutrition solutions that cater to women’s specific physiological needs. Laura Katz, the CEO of Helaina, emphasized that effera™ was developed to support women’s health comprehensively and is a testament to the power of modern biotechnology in delivering safe and precise nutritional solutions. This innovative approach marks a significant advancement in the field of precision nutrition, making tailored products more accessible and effective for women.
Recognizing the pioneering efforts of Levelle Nutrition, the company recently received a Growth and Innovation Award from the Nutrition Business Journal for its commitment to developing female-centric nutritional products. In addition to the Cycle Syncing Protein, Levelle offers a range of performance gels made from real food, catering to the needs of female athletes. The company is now expanding its product line to develop a protein powder specifically targeting the nutritional requirements of menopausal and post-menopausal women. Dr. Linda Alvarez, co-founder of Levelle Nutrition, highlighted the importance of providing women with nutrition products that align with their physiological needs and performance goals, emphasizing the significance of personalized nutrition tailored to women’s bodies.
Takeaways:
– Levelle Nutrition’s Cycle Syncing Protein, powered by precision-fermented lactoferrin, represents a significant advancement in personalized nutrition for women, addressing the specific nutritional needs across different phases of the menstrual cycle.
– The use of effera™, a human-identical lactoferrin, underscores the potential of precision fermentation in developing bioavailable and effective nutritional ingredients that mimic those found in human biology.
– The strong demand for the Cycle Syncing Protein highlights the market need for tailored nutrition solutions that cater to women’s physiology, signaling a shift towards more personalized and gender-specific dietary products.
– This innovative approach by Levelle Nutrition and Helaina showcases the intersection of biotechnology and nutrition, paving the way for precision nutrition to become more accessible and impactful in supporting women’s health and well-being.
Tags: formulation, biotech, precision nutrition
Read more on vegconomist.com